Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company announcement – No. 23 / 2019 Total number of shares and voting rights in Zealand Pharma at June 30, 2019 Copenhagen, June 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no....
-
Press release – No. 15 / 2019 Zealand Pharma introduces new website to support people living with short bowel syndrome LivingWithSBS.com is a new website with information about short bowel syndrome,...
-
Company announcement – No. 22 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, June 14, 2019 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 21 / 2019 Zealand Pharma announces amendments to its Articles of Association following the granting of warrants Copenhagen, June 13, 2019 – Zealand Pharma A/S...
-
Company announcement – No. 20 / 2019 Zealand Pharma implements a new long-term incentive program and grants new warrants under the employee warrant program Copenhagen, June 13, 2019 – Zealand...
-
Press release – No. 13 / 2019 Zealand Pharma to attend Citi European Healthcare Conference Copenhagen, June 4, 2019 – Zealand Pharma Chief Executive Officer Emmanuel Dulac and Chief Medical and...
-
Company announcement – No. 18 / 2019 Total number of shares and voting rights in Zealand Pharma as of May 31, 2019 Copenhagen, June 3, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL), a...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Company announcement – No. 17 / 2019 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, May 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ:...
-
Press release – No. 12 / 2019 Zealand Pharma to attend Jefferies and Goldman Sachs Global Healthcare Conferences Copenhagen, May 27, 2019 – Zealand Pharma Chief Executive Officer Emmanuel...